• 90.2k views

Transfusion related acute lung Injury

A dangerous and sometimes fatal side effect of blood product transfusion is known as transfusion-related acute lung injury (TRALI), in which a patient has noncardiogenic pulmonary edema and fast onset lung injury as a result of the activation of immune cells in the lungs. It is a new acute lung injury (ALI), unrelated to any other ALI risk factor, that develops during or within six hours of transfusion. With fever, chills, and hypoxemic respiratory failure, it has the potential to be fatal. Its pathogenesis and diagnostic standards are still being explored given that it is a clinically diagnosed syndrome.

About the Speaker

Dr. Jagdeesh Kumar V Profile Image

Dr. Jagdeesh Kumar V

Internal Medicine Consultant, AIG Hospital

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Jagdeesh Kumar V's Talks on Assimilate

webinar
Dr. Jagdeesh Kumar V
  • 0

A dangerous and sometimes fatal side effect of blood product transfusion is known as transfusion-related acute lung injury (TRALI), in which a patient has noncardiogenic pulmonary edema and fast onset lung injury as a result of the activation of immune cells in the lungs. It is a new acute lung injury (ALI), unrelated to any other ALI risk factor, that develops during or within six hours of transfusion. With fever, chills, and hypoxemic respiratory failure, it has the potential to be fatal. Its pathogenesis and diagnostic standards are still being explored given that it is a clinically diagnosed syndrome.

webinar
Dr. Jagdeesh Kumar V
  • 0

A dangerous and sometimes fatal side effect of blood product transfusion is known as transfusion-related acute lung injury (TRALI), in which a patient has noncardiogenic pulmonary edema and fast onset lung injury as a result of the activation of immune cells in the lungs. It is a new acute lung injury (ALI), unrelated to any other ALI risk factor, that develops during or within six hours of transfusion. With fever, chills, and hypoxemic respiratory failure, it has the potential to be fatal. Its pathogenesis and diagnostic standards are still being explored given that it is a clinically diagnosed syndrome.